American Senior Communities Settles for $5.5 Million in FCA Case

A scale with the word fraud on it and some boxes

Thanks to the work of a whistleblower, the U.S. Department of Justice recently settled with an Indiana-based skilled nursing and long-term care services company for $5.5 million to resolve allegations that it violated the False Claims Act. A former American Senior Communities (ASC) employee filed a whistleblower lawsuit in 2017 alleging that that ASC was…

Read More

Three Dozen Charged in $1.2 Billion Healthcare Fraud Scheme

A collage of medical images including genetic testing, cell phone fraud and a knee brace.

The U.S. Department of Justice, through coordinated investigations across 13 districts, has filed criminal charges against three dozen defendants who allegedly were involved in $1.2 billion in fraudulent telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment schemes. Those charged include a telemedicine company executive, owners and executives of clinical laboratories, durable medical equipment…

Read More

DME Owners Face 55 Years Behind Bars

A collage of pictures with the words dme fraud

The owners and operators of four orthotic brace suppliers in Texas and Arkansas recently were convicted for their part in a $6.5 million kickback scheme that included federal anti-kickback law violations. Husband and wife Bruce and Bobbi Stroud, along with Kenric Griffin, owned and operated New Horizons Durable Medical Equipment, Striffin Medical Supply, 4B Ortho…

Read More

States Benefit from Multimillion-Dollar FCA Urine Test Lab Settlement

A person holding a plastic tube with yellow liquid in it.

Several states are now benefiting from a multimillion-dollar settlement agreement signed late last year by a Nevada clinical lab and two of its owners who were charged with submitting false claims for payment to federal healthcare programs. Nevada Attorney General Aaron D. Ford recently announced that his state would receive $335,000 of the settlement money…

Read More

OIG Gives Okay to Cost-Sharing Subsidy in Clinical Trial

A heart with electrical signals coming out of it.

A company that makes a medical device that uses a patient’s cells to treat ischemic systolic heart failure – a life-threatening cardiac condition – would not face sanctions if it paid Medicare participants’ cost-sharing obligations they would otherwise owe for reimbursable items and services provided during the 2-year study. That was the finding of a…

Read More

Pharma Distributor Pays $13.1M to Settle FCA Allegations

A pair of handcuffs and pills on top of a newspaper.

Cardinal Health became the target of whistleblowers who alleged that the Ohio-based pharmaceutical distributor recruited new customers by offering and paying cash bonuses to physicians to purchase drugs from them instead of its competitors for use on Medicare and Medicaid patients in violation of the Anti-Kickback Statute and False Claims Act. As a result, the…

Read More

OIG Gives Blessing to Alzheimer’s Study Payment Arrangement

A picture of several different sections of the brain.

On September 29, the U.S. Department of Health and Human Services Office of Inspector General issued a favorable advisory opinion regarding the proposed subsidization of certain Medicare cost-sharing obligations relating to a clinical study of Alzheimer’s disease. The requestor is a professional medical society that represents radiologists and a charity that provides support and research…

Read More